Abstract
This review continues from a previous review on this topic, which was published in the December issue. In that review, the role of positron emission tomography in lung cancer, lymphoma, breast cancer, head and neck cancer, gastroesophageal cancer, colorectal cancer, malignant melanoma, bone tumors and ovarian cancer was discussed. In this review, the role of positron emission tomography in other malignancies, such as gynecological malignancies other than ovary, pancreatic cancer, hepatocellular cancer, gastrointestinal tumors, urological malignancies, neuroendocrine tumors, adrenocortical tumors, soft-tissue sarcomas, pituitary and brain tumors, is discussed.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 625-640 |
| Number of pages | 16 |
| Journal | Expert Review of Anticancer Therapy |
| Volume | 6 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2006 |
| Externally published | Yes |
Keywords
- Adrenocortical tumors
- Brain tumors
- Cervical cancer
- Fluorodeoxyglucose
- Gastrointestinal tumor
- Neuroendocrine tumor
- Oncology
- Pancreatic cancer
- Positron emission tomography
- Prostate cancer
- Soft-tissue sarcoma
